Ebola Virus Vaccine Passes Initial Trials
From Times Wire Reports
The first vaccine designed to prevent infection with the lethal Ebola virus has passed initial safety tests in humans and has shown promising signs that it may indeed protect people from contracting the disease, government scientists reported.
Just 21 people received the vaccine in this early-stage testing. Dr. Gary Nabel and colleagues at the National Institutes of Health’s Vaccine Research Center developed a vaccine made of DNA strands that encoded three Ebola proteins. They boosted that vaccine with a weakened cold-related virus, and the combination shielded monkeys exposed to Ebola.
